Neural stem cells rescue cognitive and motor dysfunction in a transgenic model of dementia with lewy bodies through a BDNF-dependent mechanism

Stem Cell Reports

Volumn 5, Issue 5, 2015, Pages 791-804

  Goldberg, Natalie R S ^a,b   Caesar, Jacqueline ^b   Park, Ashley ^b   Sedgh, Shawn ^b   Finogenov, Gilana ^b   Masliah, Eliezer ^c   Davis, Joy ^b   Blurton Jones, Mathew ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 2 RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; NESTIN; NEUROTROPHIN; TYROSINE 3 MONOOXYGENASE; VESICULAR GLUTAMATE TRANSPORTER 1; VESICULAR GLUTAMATE TRANSPORTER 2; VIMENTIN; DOPAMINE; GLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; COGNITION; COGNITIVE DEFECT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORPUS STRIATUM; DIFFUSE LEWY BODY DISEASE; HIPPOCAMPUS; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; GENETICS; LEWY BODY DISEASE; LOCOMOTION; METABOLISM; TRANSPLANTATION;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; COGNITION; CORPUS STRIATUM; DOPAMINE; GLUTAMIC ACID; LEWY BODY DISEASE; LOCOMOTION; MICE; MICE, INBRED C57BL; NEURAL STEM CELLS;

EID: 84946743500     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2015.09.008     Document Type: Article

References (49)

1. E. Aarts, A.A. Nusselein, P. Smittenaar, R.C. Helmich, B.R. Bloem, and R. Cools Greater striatal responses to medication in Parkinson's disease are associated with better task-switching but worse reward performance Neuropsychologia 62 2014 390 397
2. R.L. Albin, A.B. Young, and J.B. Penney The functional anatomy of disorders of the basal ganglia Trends Neurosci. 18 1995 63 64
3. D. Amschl, J. Neddens, D. Havas, S. Flunkert, R. Rabl, H. Römer, E. Rockenstein, E. Masliah, M. Windisch, and B. Hutter-Paier Time course and progression of wild type α-synuclein accumulation in a transgenic mouse model BMC Neurosci. 14 2013 6
4. D. Bambah-Mukku, A. Travaglia, D.Y. Chen, G. Pollonini, and C.M. Alberini A positive autoregulatory BDNF feedback loop via C/EBPβ mediates hippocampal memory consolidation J. Neurosci. 34 2014 12547 12559
5. M. Blurton-Jones, M. Kitazawa, H. Martinez-Coria, N.A. Castello, F.J. Müller, J.F. Loring, T.R. Yamasaki, W.W. Poon, K.N. Green, and F.M. LaFerla Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease Proc. Natl. Acad. Sci. USA 106 2009 13594 13599
6. S.B. Bonelli, G. Ransmayr, M. Steffelbauer, T. Lukas, C. Lampl, and M. Deibl L-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia Neurology 63 2004 376 378
7. K.E. Bosse, F.K. Maina, J.A. Birbeck, M.M. France, J.J. Roberts, M.L. Colombo, and T.A. Mathews Aberrant striatal dopamine transmitter dynamics in brain-derived neurotrophic factor-deficient mice J. Neurochem. 120 2012 385 395
8. M. Canossa, O. Griesbeck, B. Berninger, G. Campana, R. Kolbeck, and H. Thoenen Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity Proc. Natl. Acad. Sci. USA 94 1997 13279 13286
9. S.J. Colloby, S. McParland, J.T. O'Brien, and J. Attems Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias Brain 135 2012 2798 2808
10. P. Desplats, H.J. Lee, E.J. Bae, C. Patrick, E. Rockenstein, L. Crews, B. Spencer, E. Masliah, and S.J. Lee Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein Proc. Natl. Acad. Sci. USA 106 2009 13010 13015
11. M.J. Docherty, and D.J. Burn Parkinson's disease dementia Curr. Neurol. Neurosci. Rep. 10 2010 292 298
12. B. Dubois, and B. Pillon Cognitive deficits in Parkinson's disease J. Neurol. 244 1997 2 8
13. K.B. Ferenz, R.E. Gast, K. Rose, I.E. Finger, A. Hasche, and J. Krieglstein Nerve growth factor and brain-derived neurotrophic factor but not granulocyte colony-stimulating factor, nimodipine and dizocilpine, require ATP for neuroprotective activity after oxygen-glucose deprivation of primary neurons Brain Res. 1448 2012 20 26
14. P.O. Fernagut, C.B. Hutson, S.M. Fleming, N.A. Tetreaut, J. Salcedo, E. Masliah, and M.F. Chesselet Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression Synapse 61 2007 991 1001
15. K. Gottmann, T. Mittmann, and V. Lessmann BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses Exp. Brain Res. 199 2009 203 234
16. B. Granseth, F.K. Andersson, and S.H. Lindström The initial stage of reversal learning is impaired in mice hemizygous for the vesicular glutamate transporter (VGluT1) Genes Brain Behav. 14 2015 477 485
17. J.T. Greenamyre Glutamate-dopamine interactions in the basal ganglia: relationship to Parkinson's disease J. Neural Transm. 91 1993 255 269
18. G.M. Halliday, J.B. Leverenz, J.S. Schneider, and C.H. Adler The neurobiological basis of cognitive impairment in Parkinson's disease Mov. Disord. 29 2014 634 650
19. C. Hansen, E. Angot, A.L. Bergström, J.A. Steiner, L. Pieri, G. Paul, T.F. Outeiro, R. Melki, P. Kallunki, K. Fog, and et al. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells J. Clin. Invest. 121 2011 715 725
20. D.G. Herrera, J.M. Garcia-Verdugo, and A. Alvarez-Buylla Adult-derived neural precursors transplanted into multiple regions in the adult brain Ann. Neurol. 46 1999 867 877
21. C.Y. Hsu, C.S. Hung, H.M. Chang, W.C. Liao, S.C. Ho, and Y.J. Ho Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia Neuropharmacology 91 2015 43 56
22. C. Hyman, M. Juhasz, C. Jackson, P. Wright, N.Y. Ip, and R.M. Lindsay Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon J. Neurosci. 14 1994 335 347
23. H.J. Kim, B.S. Jeon, S.H. Paek, K.M. Lee, J.Y. Kim, J.Y. Lee, H.J. Kim, J.Y. Yun, Y.E. Kim, H.J. Yang, and G. Ehm Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease J. Neurol. 261 2014 1090 1096
24. S. König, A. Hasche, S. Pallast, J. Krieglstein, and S. Klumpp Detection of ATP-binding to growth factors J. Am. Soc. Mass Spectrom. 19 2008 91 95
25. A.J. Lees, and E. Smith Cognitive deficits in the early stages of Parkinson's disease Brain 106 1983 257 270
26. J.B. Leverenz, G.S. Watson, J. Shofer, C.P. Zabetian, J. Zhang, and T.J. Montine Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease Parkinsonism Relat. Disord. 17 2011 61 64
27. S.E. Marsh, and M. Blurton-Jones Examining the mechanisms that link β-amyloid and α-synuclein pathologies Alzheimers Res. Ther. 4 2012 11
28. E. Masliah, E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, A. Takeda, Y. Sagara, A. Sisk, and L. Mucke Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders Science 287 2000 1265 1269
29. E. Masliah, E. Rockenstein, M. Mante, L. Crews, B. Spencer, A. Adame, C. Patrick, M. Trejo, K. Ubhi, T.T. Rohn, and et al. Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease PLoS ONE 6 2011 e19338
30. A. Massie, S. Goursaud, A. Schallier, K. Vermoesen, C.K. Meshul, E. Hermans, and Y. Michotte Time-dependent changes in GLT-1 functioning in striatum of hemi-Parkinson rats Neurochem. Int. 57 2010 572 578
31. M.C. Mayo, and Y. Bordelon Dementia with Lewy bodies Semin. Neurol. 34 2014 182 188
32. I.G. McKeith, D.W. Dickson, J. Lowe, M. Emre, J.T. O'Brien, H. Feldman, J. Cummings, J.E. Duda, C. Lippa, E.K. Perry, et al. Consortium on DLB Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 2005 1863 1872
33. C.V. Melo, M. Mele, M. Curcio, D. Comprido, C.G. Silva, and C.B. Duarte BDNF regulates the expression and distribution of vesicular glutamate transporters in cultured hippocampal neurons PLoS ONE 8 2013 e53793
34. H. Mizumoto, K. Mizumoto, M.A. Shatos, H. Klassen, and M.J. Young Retinal transplantation of neural progenitor cells derived from the brain of GFP transgenic mice Vision Res. 43 2003 1699 1708
35. S.J. Mowla, H.F. Farhadi, S. Pareek, J.K. Atwal, S.J. Morris, N.G. Seidah, and R.A. Murphy Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor J. Biol. Chem. 276 2001 12660 12666
36. J.D. Pita-Almenar, S. Zou, C.M. Colbert, and A. Eskin Relationship between increase in astrocytic GLT-1 glutamate transport and late-LTP Learn. Mem. 19 2012 615 626
37. D.E. Redmond Jr., K.B. Bjugstad, Y.D. Teng, V. Ourednik, J. Ourednik, D.R. Wakeman, X.H. Parsons, R. Gonzalez, B.C. Blanchard, S.U. Kim, and et al. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells Proc. Natl. Acad. Sci. USA 104 2007 12175 12180
38. T.W. Robbins, and R. Cools Cognitive deficits in Parkinson's disease: a cognitive neuroscience perspective Mov. Disord. 29 2014 597 607
39. E. Rockenstein, M. Mallory, M. Hashimoto, D. Song, C.W. Shults, I. Lang, and E. Masliah Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters J. Neurosci. Res. 68 2002 568 578
40. A. Rodriguez-Kern, M. Gegelashvili, A. Schousboe, J. Zhang, L. Sung, and G. Gegelashvili Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-kappaB Neurochem. Int. 43 2003 363 370
41. A.R. Saha, N.N. Ninkina, D.P. Hanger, B.H. Anderton, A.M. Davies, and V.L. Buchman Induction of neuronal death by alpha-synuclein Eur. J. Neurosci. 12 2000 3073 3077
42. M.F. Salvatore, R.W. Davis, J.C. Arnold, and T. Chotibut Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser(19) Exp. Neurol. 234 2012 428 436
43. J.A. Siuciak, C. Boylan, M. Fritsche, C.A. Altar, and R.M. Lindsay BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration Brain Res. 710 1996 11 20
44. T. Stewart, C. Liu, C. Ginghina, K.C. Cain, P. Auinger, B. Cholerton, M. Shi, J. Zhang Parkinson Study Group DATATOP Investigators Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort Am. J. Pathol. 184 2014 966 975
45. S.A. Vann Jones, and J.T. O'Brien The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies Psychol. Med. 44 2014 673 683
46. O. von Bohlen und Halbach, L. Minichiello, and K. Unsicker Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra FASEB J. 19 2005 1740 1742
47. T.R. Yamasaki, M. Blurton-Jones, D.A. Morrissette, M. Kitazawa, S. Oddo, and F.M. LaFerla Neural stem cells improve memory in an inducible mouse model of neuronal loss J. Neurosci. 27 2007 11925 11933
48. Y. Yuan, J. Sun, M. Zhao, J. Hu, X. Wang, G. Du, and N.H. Chen Overexpression of alpha-synuclein down-regulates BDNF expression Cell. Mol. Neurobiol. 30 2010 939 946
49. M. Ziebell, B.B. Andersen, L.H. Pinborg, G.M. Knudsen, J. Stokholm, G. Thomsen, M. Karlsborg, P. Høgh, M.L. Mørk, and S.G. Hasselbalch Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies J. Nucl. Med. 54 2013 1072 1076